# Pain Control in Colorectal Surgery: Liposomal Bupivacaine Block Versus Intravenous Lidociane

> **NCT04005859** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 61 (actual)

## Conditions studied

- Colorectal Disorders

## Interventions

- **DRUG:** Exparel
- **DRUG:** IV Lidocaine

## Key facts

- **NCT ID:** NCT04005859
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-22
- **Primary completion:** 2019-05-09
- **Final completion:** 2021-07-20
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04005859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04005859, "Pain Control in Colorectal Surgery: Liposomal Bupivacaine Block Versus Intravenous Lidociane". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04005859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*